Welcome to the PD-1 Immunotherapy trial at MHOA
Now enrolling patients for a PD-1 Immunotherapy trial at MHOA in New York City
This study will investigate Pembrolizimab plus Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone for patients not eligible for treatment with stem cell transplantation.
MHOA Principle Investigator
Alec Goldenberg, M.D.